Longitudinal outcomes of a work inclusion program in mental health departments in the city of Milan.

Work inclusion mental illness psychiatric disabilities supported employment vocational rehabilitation

Journal

The International journal of social psychiatry
ISSN: 1741-2854
Titre abrégé: Int J Soc Psychiatry
Pays: England
ID NLM: 0374726

Informations de publication

Date de publication:
05 Feb 2024
Historique:
medline: 5 2 2024
pubmed: 5 2 2024
entrez: 5 2 2024
Statut: aheadofprint

Résumé

Work functioning impairment is a key diagnostic and prognostic criterion in patients with psychiatric disorders and work inclusion is a major goal of their therapeutic pathway. Since 2009, the Regional Innovative Program (PIR) TR106, promoted by ASST Fatebenefratelli-Sacco of Milan in collaboration with other Departments of Mental Health and Addictions (DSMDs) in the town of Milan (Italy), has been developing the employment inclusion of psychiatric patients. The objective of this study is to evaluate its outcomes over 8 years of observation. We reported the results of a retrospective epidemiologic analysis on 2,142 interventions on 1,066 patients recruited, investigating PIR TR106 outcomes per year focusing on different subgroups. We focused on 'positive', 'negative', and 'other' outcomes. We preliminary calculated job maintenance interventions (5%, 107) and excluded these interventions from the overall. We observed 29 job firing (1.4%) and 15 job resignations (0.7%) as negative results (equal to 2.2% of the total) and 388 job hiring (16.6%), 647 traineeships (31.8%), and 413 work formation (20.3%) as positive outcomes (equal to 68.75%). In other outcomes (29.1%) we found 305 dismissals from PIR TR 106 (15%) and transitory outcomes (14.1%).Job hiring increased from 8.9% in 2012 to 23.8 % in 2019 ( PIR-TR106 represents a territorial employment inclusion program with progressively increasing effectiveness and specificity, as suggested by changes in outcomes during the 8-year observation. The adaptive capacity and sustainability of the intervention are worth further investigation.

Sections du résumé

BACKGROUND UNASSIGNED
Work functioning impairment is a key diagnostic and prognostic criterion in patients with psychiatric disorders and work inclusion is a major goal of their therapeutic pathway. Since 2009, the Regional Innovative Program (PIR) TR106, promoted by ASST Fatebenefratelli-Sacco of Milan in collaboration with other Departments of Mental Health and Addictions (DSMDs) in the town of Milan (Italy), has been developing the employment inclusion of psychiatric patients.
AIMS UNASSIGNED
The objective of this study is to evaluate its outcomes over 8 years of observation.
METHOD UNASSIGNED
We reported the results of a retrospective epidemiologic analysis on 2,142 interventions on 1,066 patients recruited, investigating PIR TR106 outcomes per year focusing on different subgroups. We focused on 'positive', 'negative', and 'other' outcomes.
RESULTS UNASSIGNED
We preliminary calculated job maintenance interventions (5%, 107) and excluded these interventions from the overall. We observed 29 job firing (1.4%) and 15 job resignations (0.7%) as negative results (equal to 2.2% of the total) and 388 job hiring (16.6%), 647 traineeships (31.8%), and 413 work formation (20.3%) as positive outcomes (equal to 68.75%). In other outcomes (29.1%) we found 305 dismissals from PIR TR 106 (15%) and transitory outcomes (14.1%).Job hiring increased from 8.9% in 2012 to 23.8 % in 2019 (
CONCLUSIONS UNASSIGNED
PIR-TR106 represents a territorial employment inclusion program with progressively increasing effectiveness and specificity, as suggested by changes in outcomes during the 8-year observation. The adaptive capacity and sustainability of the intervention are worth further investigation.

Identifiants

pubmed: 38312065
doi: 10.1177/00207640231217177
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

207640231217177

Auteurs

Simone Vanzetto (S)

Department of Biomedical and Clinical Sciences, Department of Mental Health and Addictions, ASST Fatebenefratelli Sacco, University of Milan, Italy.

Andrea Quarenghi (A)

Department of Biomedical and Clinical Sciences, Department of Mental Health and Addictions, ASST Fatebenefratelli Sacco, University of Milan, Italy.

Alberto Varinelli (A)

Department of Biomedical and Clinical Sciences, Department of Mental Health and Addictions, ASST Fatebenefratelli Sacco, University of Milan, Italy.

Chiara Dragoni (C)

Department of Biomedical and Clinical Sciences, Department of Mental Health and Addictions, ASST Fatebenefratelli Sacco, University of Milan, Italy.

Dario Conti (D)

Department of Biomedical and Clinical Sciences, Department of Mental Health and Addictions, ASST Fatebenefratelli Sacco, University of Milan, Italy.

Maria Boscacci (M)

Department of Biomedical and Clinical Sciences, Department of Mental Health and Addictions, ASST Fatebenefratelli Sacco, University of Milan, Italy.

Giuseppe Carrà (G)

Department of Mental Health and Addiction Services, ASST Nord Milano, Italy.
Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.

Mauro Percudani (M)

Department of Mental Health and Addiction Services, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Carla Morganti (C)

Department of Mental Health and Addiction Services, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Orsola Gambini (O)

Department of Mental Health, ASST Santi Paolo e Carlo, Milan, Italy.
CRC 'Aldo Ravelli' for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Lombardy, Italy.
Department of Health Sciences, University of Milan, Italy.

Valentina Barbieri (V)

Department of Mental Health, ASST Santi Paolo e Carlo, Milan, Italy.

Paolo Brambilla (P)

Department of Neurosciences and Mental Health, IRCCS Fondazione Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Italy.
Department of Pathophysiology and Transplantation, University of Milan, Italy.

Matteo Lazzaretti (M)

Department of Neurosciences and Mental Health, IRCCS Fondazione Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Italy.

Paola Rubelli (P)

Department of Biomedical and Clinical Sciences, Department of Mental Health and Addictions, ASST Fatebenefratelli Sacco, University of Milan, Italy.

Claudio Mencacci (C)

Department of Biomedical and Clinical Sciences, Department of Mental Health and Addictions, ASST Fatebenefratelli Sacco, University of Milan, Italy.

Antonio Fusi (A)

Department of Biomedical and Clinical Sciences, Department of Mental Health and Addictions, ASST Fatebenefratelli Sacco, University of Milan, Italy.

Caterina Viganò (C)

Department of Biomedical and Clinical Sciences, Department of Mental Health and Addictions, ASST Fatebenefratelli Sacco, University of Milan, Italy.

Bernardo Dell'Osso (B)

Department of Biomedical and Clinical Sciences, Department of Mental Health and Addictions, ASST Fatebenefratelli Sacco, University of Milan, Italy.
CRC 'Aldo Ravelli' for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Lombardy, Italy.
Department of Psychiatry and Behavioural Sciences, Bipolar Disorders Clinic, Stanford Medical School, Stanford University, CA, USA.
Neuroscience Research Center, Department of Biomedical and Clinical Sciences, University of Milan, Italy.

Classifications MeSH